UK dividends calendar - next 7 days Read More
Amgen, AstraZeneca new asthma drug gets positive phase three results Read More
LONDON MARKET MIDDAY: Stocks hover amid caution ahead of US jobs data Read More
UPDATE: AstraZeneca and EU reach settlement over vaccine dispute Read More
LONDON MARKET OPEN: Ashmore falls after mixed annual results Read More
AstraZeneca drug Ultomiris approved for use on children in EU Read More
LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC Read More
TOP NEWS: Glaxo and partner start late-stage trial of Covid-19 vaccine Read More
LONDON MARKET MIDDAY: Stocks lower; PureGym continues to mull float Read More
LONDON MARKET OPEN: CRH buoyed by US infrastructure spending bill Read More
TOP NEWS: AstraZeneca's Forxiga treatment wins approval in Japan Read More
Pfizer, Astra jab protection wanes within six months - phone app study Read More
LONDON MARKET MIDDAY: Retailers lead midcaps up but FTSE 100 struggles Read More
TOP NEWS: AstraZeneca sees positive results for Covid-19 treatment Read More
LONDON MARKET PRE-OPEN: Astra works on Covid cocktail; UK sales falter Read More
Pfizer vaccine effectiveness declines faster than AstraZeneca – study Read More
Ireland set to halt further orders of AstraZeneca and J&J vaccines Read More
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca Read More
LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy Read More
LONDON BRIEFING: UK economy continues post-pandemic rebound Read More
